Literature DB >> 7716061

Characterization of binding sites for neuropeptide FF on T lymphocytes of the Jurkat cell line.

M Minault1, J C Lecron, S Labrouche, G Simonnet, J Gombert.   

Abstract

Neuropeptide FF (NPFF) is a neuropeptide with antiopiate properties able to antagonize the action of both endogenous and exogenous opiates. Because we have recently shown that NPFF modulates the proliferation of human T lymphocytes, we have searched for binding sites for this peptide on T lymphocytes. Our study shows that T lymphocytes of the Jurkat cell line express binding sites for [125I]YLFQPQRFamide, an iodinated analogue of NPFF. This binding is time and dose dependent, reversible, saturable, and may be resolved in two distinct components of high and low affinity. The opiate receptor agonists mu, delta, and kappa, as well the antagonist naloxone, were unable to affect binding. Beside the effects of opiates on immune cells, our results suggest that an antiopiate peptide, such as NPFF, could play a role in the modulation of the immune system.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7716061     DOI: 10.1016/0196-9781(94)00159-4

Source DB:  PubMed          Journal:  Peptides        ISSN: 0196-9781            Impact factor:   3.750


  3 in total

1.  Discovery of multiple neuropeptide families in the phylum Platyhelminthes.

Authors:  Paul McVeigh; Gunnar R Mair; Louise Atkinson; Peter Ladurner; Mostafa Zamanian; Ekaterina Novozhilova; Nikki J Marks; Tim A Day; Aaron G Maule
Journal:  Int J Parasitol       Date:  2009-04-08       Impact factor: 3.981

2.  Association analysis for udder health based on SNP-panel and sequence data in Danish Holsteins.

Authors:  Xiaoping Wu; Mogens S Lund; Goutam Sahana; Bernt Guldbrandtsen; Dongxiao Sun; Qin Zhang; Guosheng Su
Journal:  Genet Sel Evol       Date:  2015-06-19       Impact factor: 4.297

3.  In Vitro Activities of Kissorphin, a Novel Hexapeptide KiSS-1 Derivative, in Neuronal Cells.

Authors:  Nathaniel G N Milton
Journal:  J Amino Acids       Date:  2012-07-09
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.